INSMED Inc (INSM) › Cash & EquivalentsINSMED Inc (INSM) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2010: $10.74M2011: $14.85M2012: $90.78M2013: $113.89M2014: $159.23M2015: $282.88M2016: $162.59M2017: $381.17M2018: $495.07M2019: $487.43M2020: $532.76M2021: $716.78M2022: $1.07B2023: $482.37M2024: $555.03M2025: $510.44M$510.44M2010Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$510.44M-8.0%2024$555.03M+15.1%2023$482.37M-55.1%2022$1.07B+49.8%2021$716.78M+34.5%2020$532.76M+9.3%2019$487.43M-1.5%2018$495.07M+29.9%2017$381.17M+134.4%2016$162.59M-42.5%2015$282.88M+77.7%2014$159.23M+39.8%2013$113.89M+25.5%2012$90.78M+511.4%2011$14.85M+38.2%2010$10.74M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share